gmp
gmp

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): CSF-1

            Therapeutic Area: Ophthalmology Product Name: PresbiDrops

            Highest Development Status: Phase II Product Type: Large molecule

            Partner/Sponsor/Collaborator: Bluestem Capital

            Deal Size: $30.0 million Upfront Cash: Undisclosed

            Deal Type: Series C Financing September 10, 2020

            Details:

            Proceeds from the financing will be used to advance Orasis’ lead eye drop candidate for the treatment of presbyopia symptoms through completion of its Phase 3 clinical trials.